Ret Proto-Oncogene antibody (AA 713-1017)
RET
Reactivity: Human
WB, IHC
Host: Mouse
Monoclonal
OTI5C5
unconjugated
-
-
Target
See all Ret Proto-Oncogene (RET) Antibodies
-
Ret Proto-Oncogene (RET)
-
Binding Specificity
-
AA 713-1017
-
Reactivity
-
Human
-
Host
-
Mouse
-
Clonality
-
Monoclonal
-
Conjugate
-
This Ret Proto-Oncogene antibody is un-conjugated
-
Application
-
Western Blotting (WB), Immunohistochemistry (IHC)
-
Purification
-
Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
-
Human recombinant protein fragment corresponding to amino acids 713-1017 of human RET(NP_066124) produced in E.coli.
-
Clone
-
OTI5C5
-
Isotype
-
IgG1
-
Top Product
-
Discover our top product RET Primary Antibody
-
-
-
Application Notes
-
WB 1:2000, IHC 1:150,
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
1 mg/mL
-
-
Target
-
Ret Proto-Oncogene (RET)
-
Alternative Name
-
RET (RET Products)
-
Synonyms
-
c-ret antibody, cret antibody, etID315074.13 antibody, ret1 antibody, wu:fd13h01 antibody, X-ret antibody, ret-A antibody, xret antibody, RET antibody, MTC1 antibody, CDHF12 antibody, CDHR16 antibody, HSCR1 antibody, MEN2A antibody, MEN2B antibody, PTC antibody, RET-ELE1 antibody, RET51 antibody, RET9 antibody, c-Ret antibody, ret proto-oncogene receptor tyrosine kinase antibody, ret proto-oncogene S homeolog antibody, ret proto-oncogene antibody, ret antibody, ret.S antibody, RET antibody, Ret antibody
-
Molecular Weight
-
124.1 kDa
-
NCBI Accession
-
NM_020975
-
HGNC
-
5979
-
Pathways
-
RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-